Thank you for your factual contributions JB. I have learned a lot from your posts and I appreciate the time you spend sharing your information. I have been invested since May and I hold a high average cost because of my FOMO tuition. Another thing I learned is that no amount of positive thinking or cursing will change the timeline or SP. Everything depends on supply and demand.
I invested in RLFTF because of VIP - in the ancient war against microorganisms mammals evolved VIP, a protein so perfect that it remains unchanged and is identical in humans and mice even today. The ‘inhibit viral replication, stop the cytokine storm, protect aveolar type II cells’,
etc. is just scratching the surface of VIP applications. Thanks to COVID-19, we are all presented with an unique investment opportunity because when will we ever be able to own a product with global demand? GLOBAL. I am not talking about “I want an iphone” demand but rather “I don’t want to die” demand.
It doesn’t matter what the FDA motives are. It is inevitable the data will be released and if the FDA drags its feet acting on data from a gold standard double blind RCT study then the rest of the world and the respective regulatory agencies are free to use the study to make their own decisions. The US is big but the rest of the world is bigger. RLFTF gets 50% of sales profits in US, Canada, and Israel/ 85% Europe/ 80% rest of the world. An effective drug which is an endogenously occurring peptide in humans so it is safe AND cheap to produce? Europe, China, India... Supply and demand. Good for Covid and beyond. IMHO. GLTA
Best,
TB
